Shiva Bhowmik is the Founder and Chief Strategy Officer of Trio Pharmaceuticals. He holds an M.Tech from IIT Kharagpur and a Ph.D. from Purdue University. He has a strong background in drug discovery and antibody therapeutics, leading Trio's efforts to develop novel cancer treatments.
Trio Pharmaceuticals is a cancer therapeutics company developing dual-action antibody drugs. Its TRIO™ platform creates antibody-drug conjugates (ADCs) that not only deliver cytotoxic payloads directly to tumor cells but also stimulate the immune system to fight cancer.
OpenSphere helps the world's best founders navigate US immigration and build global companies. From visa strategy to company formation, we've got you covered.
Join 2,000+ builders building world class products.
